Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

Exclusion Criteria

• •Subjects who had a medical history of severe cardiovascular, respiratory, hepatobiliary, renal, hematological, gastrointestinal, endocrinological, immunological, dermatological or neuropsychological disease
• •Subjects who have symptoms of an acute disease within 28 days before first administration
• •Subjects who have clinically significant active, chronic disease
• •Subjects who fall under the criteria below in laboratory test
• •* AST/ALT \> UNL (upper normal limit) x 2
• •* Total bilirubin \> UNL x 1.5
• •* CrCL \< 50mL/min
• •* CPK \> UNL x 2.5
• •Subjects with clinically significant low blood pressure at screening test (systolic blood pressure is less than 100 mmHg or diastolic blood pressure is less than 60 mmHg)
• •Subjects with any positive reaction in HBs Ag, anti-HCV Ab, anti-HIV Ab, VDRL tests